Neogen (NEOG) Total Current Liabilities (2011 - 2026)
Neogen (NEOG) recorded quarterly Total Current Liabilities of $150.6 million in Q1 2026, up 2.41% quarter-over-quarter from $147.0 million in Q4 2025, and up 6.66% on a YoY basis from $141.2 million in Q1 2025.
Neogen (NEOG) Total Current Liabilities (2011 - 2026) Analysis & Trends
Neogen's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $150.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 6.66% year-over-year to $150.6 million; the TTM figure through Feb 2026 stood at $150.6 million (up 6.66% YoY), while the FY2025 annual figure was $174.0 million, up 12.75% from the prior year.
- Total Current Liabilities was $150.6 million for Q1 2026 at Neogen, up from $147.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $176.6 million in Q4 2023 to a low of $65.7 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $133.9 million across 5 years, with a median of $146.2 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities surged 143.42% in 2022, then slipped 14.39% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $152.6 million in 2022, then gained by 15.77% to $176.6 million in 2023, then decreased by 14.39% to $151.2 million in 2024, then fell by 2.74% to $147.0 million in 2025, then grew by 2.41% to $150.6 million in 2026.
- The last three Total Current Liabilities figures came in at $150.6 million (Q1 2026), $147.0 million (Q4 2025), and $146.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 150.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 150.60 Mn |
| Nov 30, 2025 | 147.05 Mn |
| Aug 31, 2025 | 146.21 Mn |
| May 31, 2025 | 174.00 Mn |
| Feb 28, 2025 | 141.20 Mn |
| Nov 30, 2024 | 151.20 Mn |
| Aug 31, 2024 | 122.69 Mn |
| May 31, 2024 | 154.32 Mn |
| Feb 29, 2024 | 157.84 Mn |
| Nov 30, 2023 | 176.61 Mn |
| Aug 31, 2023 | 138.13 Mn |
| May 31, 2023 | 145.47 Mn |
| Feb 28, 2023 | 107.16 Mn |
| Nov 30, 2022 | 152.56 Mn |
| Aug 31, 2022 | 67.00 Mn |
| May 31, 2022 | 77.84 Mn |
| Feb 28, 2022 | 65.71 Mn |
| Nov 30, 2021 | 62.67 Mn |
| Aug 31, 2021 | 50.76 Mn |
| May 31, 2021 | 53.60 Mn |